<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE328nnn/GSE328358/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328358</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Investigation of the Effect and Target of SchA in the Treatment of Triple-Negative Breast Cancer</name><description>SchA, one of the key bioactive components derived from Schisandra chinensis, was found in our study to exert a significant inhibitory effect on breast cancer cell viability. To elucidate the underlying mechanism, we integrated bioinformatics analysis with network pharmacology approaches to predict potential targets of SchA. The findings suggest that SchA may exert its anti-tumor effects by modulating IDO1 (indoleamine 2,3-dioxygenase 1), providing a foundation for further mechanistic investigation.</description><dates><publication>2026/06/11</publication></dates><accession>GSE328358</accession><cross_references><GSM>GSM9679920</GSM><GSM>GSM9679923</GSM><GSM>GSM9679922</GSM><GSM>GSM9679921</GSM><GPL>29480</GPL><GSE>328358</GSE><taxon>Homo sapiens</taxon><PMID>[42220063]</PMID></cross_references></HashMap>